Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
Reading this · LD-2 reports a hired firm's fee and a registrant's reported expenses on separate lines and never both on one filing, so the two lists above are different quantities and are ranked separately rather than against each other. Firm names link to their own record as the firms chapter lands.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Health Issues
HCR
33 filings
$70K on those filings
Budget/Appropriations
BUD
26 filings
$266K on those filings
Medical/Disease Research/Clinical Labs
Bills named in the filings
The 15 most-cited of 16 bill references, extracted from the activity descriptions.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: ovarian-cancer-national-alliance.
MED
18 filings
$176K on those filings
Defense
DEF
1 filing
$10K on those filings
Note · A filing names one to several issue areas and reports a single dollar figure for the period, so the same money appears beside every issue that filing declares. The dollar column is therefore spend on filings that named this issue — it is not a split of the total, and these figures sum above it. Filing counts do not double-count.
4 filings
through 2010
S. 3493111th CongressNamed in the filings; no matching bill record on file.3 filingsthrough 2010
H.R. 2739114th CongressCancer Drug Coverage Parity Act of 20152 filingsthrough 2015
S. 1566114th CongressCancer Drug Coverage Parity Act of 20152 filingsthrough 2015
H.Res. 301113th CongressExpressing support for designation of September 2013 as National Ovarian Cancer Awareness Month.2 filingsthrough 2013
H.R. 3689110th CongressOvarian Cancer Biomarker Research Act of 20072 filingsthrough 2008
H.Res. 671110th CongressSupporting the goals and ideals of National Ovarian Cancer Awareness Month.2 filingsthrough 2008
S. 2569110th CongressOvarian Cancer Biomarker Research Act of 20082 filingsthrough 2008
S.Res. 311110th CongressA resolution supporting the goals and ideals of National Ovarian Cancer Awareness Month.2 filingsthrough 2008
H.R. 1735114th CongressNational Defense Authorization Act for Fiscal Year 20161 filingthrough 2015
S. 1695114th CongressDepartments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 20161 filingthrough 2015
H.R. 2457113th CongressWomen's Preventive Health Awareness Campaign1 filingthrough 2014
H.Res. 697113th CongressExpressing support for the designation of September 2014 as National Ovarian Cancer Awareness Month.1 filingthrough 2014
How these are found · Bill references are extracted from the free-text activity description each filing writes, then matched to the Congress in session that filing year. A reference we can't match to a bill on file is still shown, unlinked — we cite what the filing said rather than guess at what it meant. Naming a bill is not a position on it: LD-2 records that a client lobbied on the bill, never which side.
through 2015
LAURA KOONTZ phdOvarian Cancer National AllianceCovered position: Director of Policy9 filingsthrough 2015
David C ZookOvarian Cancer National Alliance7 filingsthrough 2011
John DobsonFaegre Drinker Biddle & Reath LLP4 filingsthrough 2009
Chad RamseyOvarian Cancer National Alliance3 filingsthrough 2016
Rebecca McgrathFaegre Drinker Biddle & Reath LLPCovered position: Leg. Assist./Scheduler, Sen. Christopher Dodd2 filingsthrough 2014
